AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery
The strategies detailed here define a next-generation precision-oncology paradigm capable of anticipating tumor evolution, overcoming resistance, and preventing metastatic relapse, by uniting AI-guided design, circadian reprogramming, dormancy eradication, and logic-gated delivery.